Stanford Medicine researchers discuss prevention efforts and the importance of addressing the long-term health of people living with HIV.
The U.S. Preventive Services Task Force now recommends HIV screening for those aged 15-65 and increased use of PrEP, a pill that helps prevent infection.
The U.S. Preventative Services Task Force encourages those who are at high risk of contracting HIV to take a daily pre-exposure drug.
Antiretroviral therapy, a breakthrough treatment for HIV infection, suppresses the levels of circulating HIV viral particles in the blood. When it works, cancer rates drop, according to a new study. Still, even when the therapy is successful, HIV-positive individuals retain elevated rates of cancer.
There are easy ways to test for HIV, and there are reliable ways, but easy and reliable? That's hard to come by — but perhaps not for long.
The recent film "A United Kingdom" tells the story of Botswana’s maverick first president who defied convention and caused an international scandal by marrying a …
In the heat of the Ebola crisis in late 2014, Stanford’s Gene Richardson, MD, was among the brave physicians who volunteered in Sierra Leone to …
Stanford's Eran Bendavid, MD, is among the 18,000 people gathered this week in South Africa for the 21st International AIDS Conference. And he, like many others, …
PEPFAR, the U.S. government’s signature program for HIV treatment and prevention, has long supported projects in the developing world that encourage sexual abstinence and fidelity. …
People who inject drugs make up less than 1 percent of the U.S. adult population. But about 10 percent of new HIV infections in this …
Stanford chemists have developed a highly sensitive and specific tool to screen for cancer and HIV — 1000 times more sensitive than current clinical tests. …
Here in California, the drought is plenty serious. Shortages mean short showers, brown lawns, empty reservoirs and fallow fields. But in sub-Saharan Africa, drought spreads …
I, personally, have never had trouble distinguishing a human being from a chimp. I look, and I know. But I'm not a molecular biologist. Today's …
In the last decade, millions more people in the developing world have gained access to anti-viral drugs to treat HIV, with nearly 12 million now …
Last week, John Boothroyd, PhD, kicked off Stanford’s first Disease Detective lecture series with a fascinating tale about how his lab invented a simple biochemical …
